Matthew Kostura
Company: Bantam Pharmaceutical
Job title: Chief Scientific Officer
Seminars:
Targeting Mitochondrial Quality Control as a Therapeutic Strategy for Cancer 10:30 am
Uncovering novel modulators of mitochondrial protein quality control as therapy for relapsed/refractory diffuse large B-cell lymphomas Explore the key challenges in developing agents directed against mitochondria for cancer therapeutics Discover novel clinical biomarkers related to mitochondrial biologyRead more
day: Day Two